Pharos Capital Group has announced it has acquired a majority stake in RhythMedix.
RhythMedix, founded in 2013 and based in Mt. Laurel, N.J., is a manufacturer and provider of remote cardiac monitoring systems and related services.
Pharos, with offices in Dallas and Nashville, pursues control equity and mezzanine investments in lower and middle market companies primarily in healthcare and business services. Founded in 1998, the firm targets the provider services and non-reimbursement industries within healthcare.
Terms of the acquisition were not disclosed.